{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:05:51Z","timestamp":1789380351160,"version":"build-2803163510"},"reference-count":120,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Molecular docking is among the most widely used techniques in structure-based drug discovery and has become integral to natural-product research. Despite substantial advances in computational algorithms and artificial intelligence, the methodological quality of published docking studies on natural compounds remains highly variable, and generally accepted methodological guidelines have yet to be established. This review critically evaluates current approaches to molecular docking of natural compounds, examines the specific features of different natural-product classes and protein targets, and offers practical recommendations for the design and validation of docking studies. The review covers the main stages of molecular docking, contemporary search algorithms and scoring functions, protein and ligand preparation, the fundamental limitations of the method, strategies for result validation, and the emerging role of artificial intelligence in computational molecular modeling. A central component is a systematic methodological audit of publications within a prespecified 2025 coverage window, identified by Scopus and PubMed searches executed in August 2026. The audit assessed methodological reporting completeness only and was not intended as a systematic review of biological or pharmacological findings. The audit comprised GPT-assisted structured coding of 1127 publications, detailed full-text assessment of a random sample of 80 studies drawn entirely from the same corpus, and independent human validation of 20 randomly selected Stage 2 publications. In the 80-publication full-text sample, redocking was reported in 7.5% of publications, a qualifying redocking RMSD below 2 \u00c5 in 6.2%, positive controls in 87.5%, molecular dynamics in 41.2%, MM\/PBSA or MM\/GBSA in 12.5%, interaction analysis in 98.8%, and ADMET assessment in 35.0%. Agreement between Stage 1 and Stage 2 was 98.3% across 525 paired criterion decisions. Independent human assessment of the 20-publication validation subsample agreed with Stage 2 in 135 of 140 criterion decisions (96.4%); the five discrepancies all involved AI-coded indeterminate\/non-confirmed labels (Unconfirmed or N\/A) that the human reviewer classified as No. On the basis of these findings, we propose a practical workflow aimed at improving the reproducibility and methodological rigor of molecular docking studies of natural compounds. A complementary targeted case-enriched validation of redocking and redocking-RMSD classification included 19 publications and two human reviewers. The reviewers reached identical classifications in all 38 criterion decisions; their consensus agreed with Stage 2 in 31 of 38 decisions (81.6%), with seven revisions across four publications. Because this sample was deliberately enriched for informative and ambiguous cases, it was used to examine classification boundaries rather than to estimate prevalence. Because PubMed retrieval was restricted to free full text and the Scopus search used restricted bibliographic fields, these reporting-completeness and validation frequencies primarily characterize an accessibility-enriched corpus and may not fully generalize to subscription-only or otherwise less-accessible journals. By combining a critical appraisal of current methods with a quantitative assessment of published studies and practical recommendations for standardizing the molecular docking of natural compounds, this review offers guidance for researchers in computer-aided drug design.<\/jats:p>","DOI":"10.3390\/molecules31183228","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:34:01Z","timestamp":1789378441000},"page":"3228","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Docking of Natural Products: Critical Appraisal of Current Methodology and Practical Guidelines"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0194-8739","authenticated-orcid":false,"given":"Almagul S.","family":"Makhmutova","sequence":"first","affiliation":[{"name":"School of Pharmacy, Karaganda Medical University, Karaganda 100024, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazigul S.","family":"Remetova","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Karaganda Medical University, Karaganda 100024, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnissa K.","family":"Kurmantayeva","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Karaganda Medical University, Karaganda 100024, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances","volume":"14","author":"Lionta","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pinzi, L., and Rastelli, G. (2019). Molecular Docking: Shifting Paradigms in Drug Discovery. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184331"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41596-021-00597-z","article-title":"A practical guide to large-scale docking","volume":"16","author":"Bender","year":"2021","journal-title":"Nat. Protoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-2836(82)90153-X","article-title":"A geometric approach to macromolecule\u2013ligand interactions","volume":"161","author":"Kuntz","year":"1982","journal-title":"J. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. I. Method and Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"GNINA 1.0: Molecular docking with deep learning","volume":"13","author":"McNutt","year":"2021","journal-title":"J. Cheminform."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_14","unstructured":"Corso, G., St\u00e4rk, H., Jing, B., Barzilay, R., and Jaakkola, T. (2022). DiffDock: Diffusion Steps, Twists, and Turns for Molecular Docking. arXiv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105920","DOI":"10.1016\/j.isci.2022.105920","article-title":"How good are AlphaFold models for docking-based virtual screening?","volume":"26","author":"Scardino","year":"2023","journal-title":"iScience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Adzhigirey","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Le Guilloux, V., Schmidtke, P., and Tuffery, P. (2009). Fpocket: An open source platform for ligand pocket detection. BMC Bioinform., 10.","DOI":"10.1186\/1471-2105-10-168"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Che, X., and Zhang, L. (2025). Blind docking methods have been inappropriately used in most network pharmacology analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1566772"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: A drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014A free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"D1217","DOI":"10.1093\/nar\/gkx1026","article-title":"NPASS: Natural product activity and species source database for natural product research, discovery and tool development","volume":"46","author":"Zeng","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-020-00478-9","article-title":"COCONUT online: Collection of Open Natural Products database","volume":"13","author":"Sorokina","year":"2021","journal-title":"J. Cheminform."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: A software program for pKa prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: Algorithm and validation using high-quality structures from the Protein Data Bank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","article-title":"A fast flexible docking method using an incremental construction algorithm","volume":"261","author":"Rarey","year":"1996","journal-title":"J. Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00126743","article-title":"The development of a simple empirical scoring function to estimate the binding constant for a protein\u2013ligand complex of known three-dimensional structure","volume":"8","year":"1994","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1007996124545","article-title":"Empirical scoring functions. I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes","volume":"11","author":"Eldridge","year":"1997","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/jm980536j","article-title":"A general and fast scoring function for protein\u2013ligand interactions: A simplified potential approach","volume":"42","author":"Muegge","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/bioinformatics\/btq112","article-title":"A machine learning approach to predicting protein\u2013ligand binding affinity with applications to molecular docking","volume":"26","author":"Ballester","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s44371-025-00373-y","article-title":"Integrating phytochemicals and in silico methods for modern drug discovery: A comprehensive review","volume":"2","author":"Babalola","year":"2025","journal-title":"Discov. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: An overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Joshee, N., Dhekney, S.A., and Parajuli, P. (2019). Therapeutic and Medicinal Uses of Terpenes. Medicinal Plants, Springer.","DOI":"10.1007\/978-3-030-31269-5"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2174\/092986710790712147","article-title":"Recent insights into the biosynthesis and biological activities of natural xanthones","volume":"17","author":"Bohlin","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"963248","DOI":"10.1155\/2013\/963248","article-title":"Review on natural coumarin lead compounds for their pharmacological activity","volume":"2013","author":"Venugopala","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/nu2121231","article-title":"Chemistry and biochemistry of dietary polyphenols","volume":"2","author":"Tsao","year":"2010","journal-title":"Nutrients"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1039\/C6NP00021E","article-title":"Recent advances in research on lignans and neolignans","volume":"33","author":"Teponno","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.drudis.2018.05.006","article-title":"Protein\u2013peptide docking: Opportunities and challenges","volume":"23","author":"Ciemny","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jmb.2012.07.014","article-title":"The structure of DNA-bound human topoisomerase II\u03b1: Conformational mechanisms for coordinating intersubunit interactions with DNA cleavage","volume":"424","author":"Wendorff","year":"2012","journal-title":"J. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jmb.2014.02.005","article-title":"The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization","volume":"426","author":"Prota","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/prot.340220408","article-title":"Multiple modes of ligand recognition: Crystal structures of CDK2 in complex with ATP and two inhibitors","volume":"22","author":"Brandsen","year":"1995","journal-title":"Proteins"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.274.5289.948","article-title":"Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain","volume":"274","author":"Kussie","year":"1996","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1021\/cb5001197","article-title":"Structures of kibdelomycin bound to Staphylococcus aureus GyrB and ParE show a novel U-shaped binding mode","volume":"9","author":"Lu","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1073\/pnas.1300118110","article-title":"How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function","volume":"110","author":"Otero","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/bi982728m","article-title":"Ligand-Induced Conformational Changes in the Crystal Structures of Pneumocystis carinii Dihydrofolate Reductase Complexes with Folate and NADP+","volume":"38","author":"Cody","year":"1999","journal-title":"Biochemistry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/342299a0","article-title":"X-ray analysis of HIV-1 proteinase at 2.7 \u00c5 resolution confirms structural homology among retroviral enzymes","volume":"342","author":"Lapatto","year":"1989","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1093\/nar\/gku487","article-title":"Structures of HIV-1 RT\u2013RNA\/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA\/DNA: Insights into requirements for RNase H cleavage","volume":"42","author":"Das","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1074\/jbc.M116.725713","article-title":"Substrate-selective inhibition of cyclooxygenase-2 by fenamic acid derivatives is dependent on peroxide tone","volume":"291","author":"Orlando","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.1116304","article-title":"Small-molecule inhibition of TNF-\u03b1","volume":"310","author":"He","year":"2005","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0092-8674(00)81698-0","article-title":"Structure of an I\u03baB\u03b1\/NF-\u03baB complex","volume":"95","author":"Jacobs","year":"1998","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1197203","article-title":"The structure of human 5-lipoxygenase","volume":"331","author":"Gilbert","year":"2011","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/MCB.02185-07","article-title":"Crystal Structure of an Active Form of BACE1, an Enzyme Responsible for Amyloid \u03b2 Protein Production","volume":"28","author":"Shimizu","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1073\/pnas.0505975102","article-title":"Three-dimensional structure of human monoamine oxidase A (MAO-A): Relation to inhibitor selectivity","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs","volume":"50","author":"Binda","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/bi9016457","article-title":"New glucosidase inhibitors from an Ayurvedic herbal treatment for type 2 diabetes: Structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata","volume":"49","author":"Sim","year":"2010","journal-title":"Biochemistry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/bi9921182","article-title":"Subsite mapping of the human pancreatic \u03b1-amylase active site through structural, kinetic and mutagenesis techniques","volume":"39","author":"Brayer","year":"2000","journal-title":"Biochemistry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2013.03.010","article-title":"A comparative study of the binding modes of clinically used DPP-4 inhibitors","volume":"434","author":"Nabeno","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-\u03b3","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1126\/science.8128219","article-title":"Crystal structure of human protein tyrosine phosphatase 1B","volume":"263","author":"Barford","year":"1994","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature01370","article-title":"Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex","volume":"421","author":"Natesh","year":"2003","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/pro.5560010402","article-title":"The refined 1.9 \u00c5 X-ray crystal structure of human \u03b1-thrombin","volume":"1","author":"Bode","year":"1992","journal-title":"Protein Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1021\/jm070245n","article-title":"Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo [3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa","volume":"50","author":"Pinto","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature01914","article-title":"Structure of the catalytic domain of human phosphodiesterase 5 with bound sildenafil","volume":"425","author":"Sung","year":"2003","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature09853","article-title":"Crystal structure of inhibitor of \u03baB kinase \u03b2","volume":"472","author":"Xu","year":"2011","journal-title":"Nature"},{"key":"ref_75","first-page":"3984","article-title":"Crystal structure of human microsomal prostaglandin E synthase-1","volume":"112","author":"Pawelzik","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","first-page":"12413","article-title":"Structure of human inducible nitric oxide synthase oxygenase domain","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4\u2013MD2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cmdc.201300525","article-title":"Binding Mode and Structure\u2013Activity Relationships around Direct Inhibitors of the Nrf2\u2013Keap1 Complex","volume":"9","author":"Jnoff","year":"2014","journal-title":"ChemMedChem"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1021\/acs.jmedchem.9b00525","article-title":"Discovery of PQR530, a potent dual PI3K\/mTOR inhibitor","volume":"62","author":"Rageot","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Wu, W.-I., Voegtli, W.C., Sturgis, H.L., Dizon, F.P., Vigers, G.P.A., and Brandhuber, B.J. (2010). Crystal structure of human AKT1 with an allosteric inhibitor. PLoS ONE, 5.","DOI":"10.2210\/pdb3o96\/pdb"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation by ATP-competitive inhibitors","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"18281","DOI":"10.1073\/pnas.1207759109","article-title":"Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors","volume":"109","author":"McTigue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/ncomms4017","article-title":"Structural basis of AMPK regulation by small molecule activators","volume":"4","author":"Xiao","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41586-021-04212-9","article-title":"Structural basis of inhibition of the human SGLT2\u2013MAP17 glucose transporter","volume":"601","author":"Niu","year":"2022","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/acs.jmedchem.1c01856","article-title":"A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor","volume":"65","author":"Griffith","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.1621098","article-title":"An unlikely sugar substrate site in the structure of the human aldose reductase holoenzyme","volume":"257","author":"Wilson","year":"1992","journal-title":"Science"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1161269","article-title":"The crystal structure of a mammalian fatty acid synthase","volume":"321","author":"Maier","year":"2008","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"16044","DOI":"10.1038\/celldisc.2016.44","article-title":"A unified molecular mechanism for the regulation of acetyl-CoA carboxylase by phosphorylation","volume":"2","author":"Wei","year":"2016","journal-title":"Cell Discov."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0969-2126(96)00153-0","article-title":"Structure of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) in complex with fosfomycin","volume":"4","author":"Skarzynski","year":"1996","journal-title":"Structure"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nsb0895-644","article-title":"An enzyme\u2013substrate complex involved in bacterial cell wall biosynthesis","volume":"2","author":"Benson","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1126\/science.274.5295.2107","article-title":"A mechanism of drug action revealed by structural studies of enoyl reductase","volume":"274","author":"Baldock","year":"1996","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/34472","article-title":"Crystal structure of the bacterial cell-division protein FtsZ","volume":"391","author":"Amos","year":"1998","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1110\/ps.073324108","article-title":"Crystal Structure of LpxC from Pseudomonas aeruginosa Complexed with the Potent BB-78485 Inhibitor","volume":"17","author":"Mochalkin","year":"2008","journal-title":"Protein Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.cell.2020.07.033","article-title":"Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"ref_99","unstructured":"Rosas-Lemus, M., Thuiller, W., Stuart-Smith, R.D., Devictor, V., Edgar, G.J., Velez, L., Cinner, J.E., Graham, N.A.J., Renaud, J., and Hoey, A.S. (2020). High-resolution structures of the SARS-CoV-2 NSP16\u2013NSP10 complex. PLoS Biol., 18."},{"key":"ref_100","first-page":"386","article-title":"The molecular basis of hepatitis C virus protease inhibitor resistance","volume":"468","author":"Romano","year":"2010","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2003.08.031","article-title":"Structural characterization of the GSK-3\u03b2 active site using selective kinase inhibitors","volume":"333","author":"Bertrand","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41586-020-2673-2","article-title":"Structure of LRRK2 in Parkinson\u2019s disease and model for microtubule interaction","volume":"588","author":"Deniston","year":"2020","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jmb.2008.04.040","article-title":"Crystal Structures of Human 108V and 108M Catechol O-Methyltransferase","volume":"380","author":"Rutherford","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1164772","article-title":"The 2.6 \u00c5 crystal structure of a human A2A adenosine receptor bound to an antagonist","volume":"322","author":"Jaakola","year":"2008","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.2140","article-title":"Structural insights into HDAC6 tubulin deacetylation and its selective inhibition","volume":"12","author":"Miyake","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jmb.2012.08.002","article-title":"The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition","volume":"423","author":"Bertrand","year":"2012","journal-title":"J. Mol. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/jm301431y","article-title":"The 2.5 \u00c5 crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition","volume":"56","author":"Zhao","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.59598\/ME-2305-6045-2024-111-2-24-32","article-title":"Features of the incidence of breast cancer in the Republic of Kazakhstan","volume":"2","author":"Isputinova","year":"2024","journal-title":"Med. Ecol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrd1129","article-title":"Implications of protein flexibility for drug discovery","volume":"2","author":"Teague","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking!","volume":"36","author":"Chen","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/prot.21082","article-title":"Protein\u2013ligand docking: Current status and future challenges","volume":"65","author":"Sousa","year":"2006","journal-title":"Proteins"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA Methods to Estimate Ligand-Binding Affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/ja512751q","article-title":"Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field","volume":"137","author":"Wang","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1063\/1.1740409","article-title":"High-Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases","volume":"22","author":"Zwanzig","year":"1954","journal-title":"J. Chem. Phys."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep Learning Enables Rapid Identification of Potent DDR1 Kinase Inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s42256-024-00832-8","article-title":"Augmenting Large Language Models with Chemistry Tools","volume":"6","author":"Bran","year":"2024","journal-title":"Nat. Mach. Intell."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/18\/3228\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:35:49Z","timestamp":1789378549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/18\/3228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":120,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["molecules31183228"],"URL":"https:\/\/doi.org\/10.3390\/molecules31183228","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}